Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 4 , Pages 285-287 , December 2008

An update on the regulatory status of PDT photosensitizers in China

  • Zheng Huang, MD, PhD

      Affiliations

    • Corresponding Author InformationTel.: +1 303 239 3567; fax: +1 303 239 3562.

References 

  1. Huang Z. Photodynamic therapy in China: over 25 years of unique clinical experience. Part One: History and domestic photosensitisers. Photodiag Photodyn Ther. 2006;3:3–10
  2. Huang Z. Photodynamic therapy in China: over 25 years of unique clinical experience. Part Two: Clinical experience. Photodiag Photodyn Ther. 2006;3:71–84
  3. Xu DY. Research and development of photodynamic therapy photosensitizers in China. Photodiag Photodyn Ther. 2007;4:13–25
  4. Boyle R. Research and development of photodynamic therapy photosensitizers in China. Photodiag Photodyn Ther. 2007;4:12
  5. Wang XL, Wang HW, Wang HS, Xu SZ, Liao KH, Hillemanns P. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol. 2004;151:880–885
  6. Chen K, Chang BZ, Ju M, Zhang XH, Gu H. Comparative study of photodynamic therapy vs. CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial. Br J Dermatol. 2007;156:516–520
  7. Wang XL, Wang HW, Guo MX, Xu SZ. Treatment of skin cancer and pre-cancer using topical ALA-PDT – a single hospital experience. Photodiag Photodyn Ther. 2008;5:127–133
  8. Wang XL, Wang HW, Guo MX, Huang Z. Combination of immunotherapy and photodynamic therapy in the treatment of Bowenoid papulosis. Photodiag Photodyn Ther. 2007;4:88–93
  9. Li P, Sun JG, Huang CR, et al. Development and validation of a sensitive quantification method for hematoporphyrin monomethyl ether in plasma using high-performance liquid chromatography with fluorescence detection. Biomed Chromatogr. 2006;20:1277–1282
  10. Yuan KH, Li Q, Yu WL, Zhang C, Huang Z. Retrospective analysis of treatment of port wine stain birthmarks – photodynamic therapy vs. pulsed dye laser. Photodiag Photodyn Ther. 2007;4:100–105
  11. Ding X, Xu Q, Liu F, et al. Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation. Cancer Lett. 2004;216:43–54
  12. Song K, Kong B, Li L, Yang Q, Wei Y, Qu X. Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether. Cancer Sci. 2007;98:1959–1964
  13. Li JH, Song DY, Xu YG, Huang Z, Yue W. In vitro study of haematoporphyrin monomethyl ether-mediated sonodynamic effects on C6 glioma cells. Neurol Sci. 2008;29:229–235
  14. Huang HF, Chen YZ, Wu Y. ZnPcS2P2-based photodynamic therapy induces mitochondria-dependent apoptosis in K562 cells. Acta Biochim Biophys Sin (Shanghai). 2005;37:488–494
  15. Zhang Z, Jin H, Bao J, Fang F, Wei J, Wang A. Intravenous repeated-dose toxicity study of ZnPcS2P2-based-photodynamic therapy in Wistar rats. Photochem Photobiol Sci. 2006;5:1006–1017
  16. Huang HF, Chen YZ, Wu Y, Li NN, Chen P. Efficacy of ZnPcS2P2 photodynamic therapy solely or with tumor vaccines on mouse tumor models. Photodiag Photodyn Ther. 2007;4:100–105
  17. Liu W, Chen N, Jin H, et al. Intravenous repeated-dose toxicity study of ZnPcS2P2-based-photodynamic therapy in beagle dogs. Regul Toxicol Pharmacol. 2007;47:221–231
  18. Li X, Wang G, Xie H, et al. Simultaneous determination of MHD and DMD in dog plasma by high-performance liquid chromatography with fluorescence detection and its application to pharmacokinetic studies. Anal Bioanal Chem. 2006;384:958–963
  19. Wang R, Hao H, Wang G, et al. Pharmacokinetics, tissue distribution and excretion of a new photodynamic drug deuxemether. J Photochem Photobiol B. 2008;90:179–186

PII: S1572-1000(09)00006-4

doi: 10.1016/j.pdpdt.2009.01.005

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 4 , Pages 285-287 , December 2008

Article Tools

* Image Usage & Resolution